Navigation Links
Questcor Provides Donation In Support Of Children's Hospital & Research Center Oakland

HAYWARD, Calif., Dec. 17, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ:   QCOR) today announced that it has made a $25,000 donation to the Children's Hospital & Research Center Oakland in support of the Early Intervention Services program.

Children's Hospital & Research Center Oakland is a premier, not-for-profit medical center for children in Northern California, and is the only hospital in the East Bay that is 100% devoted to pediatrics. Their Early Intervention Services program supports the well-being, development and caregiving relationships of infants and young children (up to age 6) who have developmental, social-emotional and medically related vulnerabilities or disabilities.

"Questcor is committed to giving back to our local community," said Steve Cartt, Chief Operating Officer for Questcor. "We feel privileged to be able to support such a worthy institution, particularly one that is funded solely by grants and charitable contributions.  Our hope is that these funds will help improve the quality of life for some Bay Area children who are in need."

In addition to the financial contribution, Mr. Cartt noted that Questcor employees in Hayward created get well cards for children being treated at the hospital.  These cards are distributed to children on their lunch trays.  "In addition to the donation, we wanted to find a way to more personally connect with the children and their families, especially during the holiday season," Mr. Cartt said.  "This seemed to be a great way to do it."

Susan Greenwald, Director of Early Intervention Services, shared, "We're grateful for Questcor's generous donation and look forward to putting the money to good use serving children and families.  We also appreciate the time and effort Questcor employees gave to produce beautiful get-well cards.  I know they will help lift the spirits of our courageous young patients."

About Children's Hospital & Research Center
Children's Hospital & Research Center Oakland is a national leader in many pediatric specialties including hematology/oncology, neonatology, cardiology, orthopaedics, sports medicine, and neurosurgery. The hospital is one of only two solely designated California Level 1 pediatric trauma centers in the region, and has one of largest pediatric intensive care units in Northern California.  Children's is also a leading teaching hospital with an outstanding pediatric residency program and a number of unique pediatric subspecialty fellowship programs.

Children's research arm, Children's Hospital Oakland Research Institute is internationally known for its basic and clinical research.  CHORI is at the forefront of translating research into interventions for treating and preventing human diseases.  

Each year, more than 75,000 children from the San Francisco Bay Area and the country receive care.  No child is turned away because of a family's inability to pay.  For more information, please visit

About Questcor Pharmaceuticals
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Questcor's specific areas of focus are in the fields of neurology, nephrology and rheumatology, and the company is currently supporting research efforts in a variety of conditions having significant unmet medical need. For more information about Questcor, please visit

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Partnerships, Appointments, New Products, Public Offerings, and Agreements - Research Report on Questcor Pharmaceuticals, Hologic, IDEXX, Endologix, and Healthways
2. Questcor Announces Quarterly Cash Dividend and Provides Update on Share Repurchase Program
3. Questcor Pharmaceuticals to Present at the Oppenheimer Annual Healthcare Conference
4. Biologics License Applications, Event Participations, and Stock Movements - Research Report on Baxter, WellPoint, Questcor Pharmaceuticals, CareFusion, and Hologic
5. Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare
6. Questcor Honored as an "Everyday Hero" by NephCure Foundation
7. Questcor Adds G. Kelly Martin to Board of Directors
8. Questcor Pharmaceuticals to Present at the 2013 Credit Suisse Annual Healthcare Conference
9. Questcor Reports Third Quarter Financial Results
10. Questcor To Commence Phase 2 Study of Acthar for Acute Respiratory Distress Syndrome
11. Questcor Pharmaceuticals to Participate in Morgan Stanley Global Healthcare Conference
Post Your Comments:
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
(Date:11/25/2015)... , Nov. 25, 2015 Research and ... the "Membranes Market - Global Forecast to 2020" ... Asia-Pacific , accounting for 37.21% of the total ... Asia-Pacific region is projected to growth ... growth has been attributed primarily to the fast growing ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, officials ... the Narconon network, announced the release of a new cutting edge recovery program that ... has been working with drug- and alcohol-addicted individuals with the purpose to free addicts ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Smiles by ... TMJ Disorder, Bruxism, and moderate facial wrinkling. While many patients are aware of the ... the great success Botox® delivers to those suffering with discomfort, soreness, and pain as ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... 25, 2015 , ... In honor of Pulmonary Hypertension Awareness ... groups responsible for advancing care for pulmonary hypertension (PH) patients and helping to ... will receive special recognition throughout 2016 as part of PHA’s 25th anniversary celebrations. ...
(Date:11/25/2015)... MA (PRWEB) , ... November 25, 2015 , ... Many ... — fatigue, fuzzy-headedness, weight gain, cold hands, and dry skin. But many people who ... their diet and exercise regimen instead of their thyroid, especially if they don’t have ...
Breaking Medicine News(10 mins):